Trial no.:
|
PACTR201703002150349 |
Date of Approval:
|
28/03/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Aminophylline for recovery from bariatric surgery |
Official scientific title |
Effect of aminophylline on recovery criteria and respiratory parameters following laparoscopic sleeve gastrectomy in morbidly obese suffering from OSA |
Brief summary describing the background
and objectives of the trial
|
Cumulative evidence suggests that aminophylline given at the end of surgery shortens recovery time from general anesthesia and improves the quality of recovery .
Furthermore, aminophylline has been shown to decrease the depth and duration of sedation produced by barbiturates , diazepam , midazolam and Propofol. The injection of aminophylline 3 mg/kg has been shown to be associated with significant increases in bispectral index up to 10 min after its injection, while heart rate and blood pressure did not change. It appears that aminophylline has the ability to partially antagonise the sedative effects of general anaesthetics (11).
Morbidly obese patients suffer many respiratory problems including, reduced functional residual capacity, increased shunting and obstructive sleep apnea. These characteristics render them more susceptible to postoperative pulmonary complications such as pulmonary atelectasis, increased sensitivity to opioids, hypoxia and hypercarbia. Amongst these, increased sensitivity to narcotic induced respiratory depression is of particular concern. We hypothesized that aminophylline inection before awakening would speed recovery and decrease respiratory complications for morbidely obese patients with suffering obstructive sleeve apnea undergoing laparoscopic sleeve gastrectomy surgery.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
decrease respiratory complication in obese recovering from sleeve surgery,Respiratory |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Prevention |
Anticipated trial start date |
01/05/2017 |
Actual trial start date |
10/05/2017 |
Anticipated date of last follow up |
04/09/2017 |
Actual Last follow-up date |
24/10/2017 |
Anticipated target sample size (number of participants) |
110 |
Actual target sample size (number of participants) |
105 |
Recruitment status |
Completed |
Publication URL |
|
|